FDA to cut down nicotine in cigarettes to non-addictive levels

solid standards and rules for newly-regulated products will follow the new federal approach to regulate nicotine.

“[The key is] understanding the short-term impacts of tobacco use and also the decision-making process by which people smoke and how they perceive risks,” Glantz added. “When the FDA does rulemaking, they do cost benefit analyses and those analyses are heavily conditioned on what we think are incorrect assumptions about the way people make decisions about tobacco. This also ignores the shorter-term impact of tobacco use, which has a big effect on the overall cost. We’re trying to develop better models of economic and behavioral as well as health impacts of tobacco use that would help the FDA build better models.”

The FDA is expected to release guidelines describing how the new policies will be enforced shortly.   

Livia Areas-Holmblad
Author: Livia Areas-Holmblad

Livia Holmblad is an editor at Addiction Now and covers breaking news, features and everything in between. She moved to SoCal after living in NYC for about 10 years, where she worked for VICE and SinoVision as a writer, editor, host, producer, and director. Born and raised in Rio de Janeiro. Contact Livia at liviah@addictionnow.com

Summary
FDA to cut down nicotine in cigarettes to non-addictive levels
Article Name
FDA to cut down nicotine in cigarettes to non-addictive levels
Description
The U.S. Food and Drug Administration (FDA) is pursuing regulations that will lower nicotine in cigarettes to non-addictive levels. In turn, the agency hopes to also lower the rates of diseases and deaths caused by cigarettes.
Author
Livia Areas-Holmblad
Publisher Name
Addiction Now